Levemir and Vytorin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Levemir (insulin detemir recombinant) and Vytorin (ezetimibe; simvastatin). Common drug interactions include glycosylated haemoglobin increased among females and blood glucose decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Levemir and Vytorin. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.
What is Levemir?
Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. eHealthMe is studying from 13,850 Levemir users. Check the latest studies of Levemir.
What is Vytorin?
Vytorin has active ingredients of ezetimibe; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 20,084 Vytorin users. Check the latest studies of Vytorin.
77 people who take Levemir and Vytorin together, and have interactions are studied.

What are the common drug interactions of Levemir and Vytorin, by gender? *:
female:
- Glycosylated haemoglobin increased
- Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
- Confusional state
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Decreased appetite
- Dyspnoea (difficult or laboured respiration)
- Exostosis (formation of new bone on the surface of a bone)
- Myalgia (muscle pain)
- Nausea (feeling of having an urge to vomit)
- Nerve compression
male:
- Blood glucose decreased
- Blood glucose increased
- Asthenia (weakness)
- Blood glucose fluctuation
- Cardiomegaly (increased size of heart than normal)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Diarrhoea
- Dizziness
- Drug ineffective
- Fall
What are the common drug interactions of Levemir and Vytorin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Cholecystitis chronic (long lasting infection of gallbladder)
- Cholesterosis (abnormal deposition of cholesterol in tissues)
- Gallbladder disorder
- Injury
30-39:
n/a
40-49:
- Anxiety
- Chest pain
- Confusional state
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Glycosylated haemoglobin increased
- Injection site mass
- Pancreatitis acute (sudden inflammation of pancreas)
- Pulmonary embolism (blockage of the main artery of the lung)
- Renal failure acute (rapid kidney dysfunction)
50-59:
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Abdominal discomfort
- Abdominal pain
- Abnormal dreams
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Arthralgia (joint pain)
- Atelectasis (partial or complete collapse of the lung)
- Bile duct stone
- Blood magnesium decreased
- Blood pressure decreased
60+:
- Blood glucose increased
- Dizziness
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Glycosylated haemoglobin increased
- Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
- Blood glucose decreased
- Dyspnoea (difficult or laboured respiration)
- Fall
- Febrile neutropenia (fever with reduced white blood cells)
- Gastroenteritis (inflammation of stomach and intestine)
What are the existing conditions these people have? *
- High Blood Pressure: 8 people, 10.39%
- Type 2 Diabetes: 6 people, 7.79%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 7.79%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 6.49%
- Birth Control: 5 people, 6.49%
- Type 1 Diabetes: 4 people, 5.19%
- Premenstrual Syndrome: 4 people, 5.19%
- Neuropathy Peripheral (surface nerve damage): 4 people, 5.19%
- Migraine (headache): 4 people, 5.19%
- Intervertebral Disc Protrusion (spinal disc protrusion): 4 people, 5.19%
* Approximation only. Some reports may have incomplete information.
Do you take Levemir and Vytorin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Levemir and Vytorin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levemir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vytorin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levemir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vytorin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin detemir recombinant and ezetimibe; simvastatin (the active ingredients of Levemir and Vytorin, respectively), and Levemir and Vytorin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Creon and Atarax - 4 seconds ago
- Drug interactions of Solu-Medrol and Gilenya - 4 seconds ago
- Pain and Hyperpyrexia - 8 seconds ago
- Drug interactions of Celexa and Cetirizine Hydrochloride - 12 seconds ago
- Drug interactions of Copiktra and Bactrim - 13 seconds ago
- Could Wellbutrin cause Respiratory Alkalosis? - 14 seconds ago
- Could Procardia cause Blood Pressure Abnormal? - 15 seconds ago
- Could Glucotrol Xl cause Proteinuria Present? - 23 seconds ago
- Drug interactions of Cymbalta and Soma - 32 seconds ago
- Could Humatrope cause Hyperkalemia? - 33 seconds ago